LPS has been suggested to induce reduced expression of CD4 and CCR5, and to increase production of type I IFNs and release of β-chemokines that reduce infection by CCR5-using, HIV-1 envelope glycoproteins, among other mechanisms for its anti-HIV-1 effect [12]–[18]. Here, CCR5 is linked to infection.